Bausch Health Companies (BHC) EV to EBITDA (2009 - 2026)

Bausch Health Companies has disclosed EV to EBITDA across 18 years of filings, most recently posting 1.32 for Q2 2026.

• In Q2 2026, EV to EBITDA fell 64.15% year-over-year to 1.32; the TTM figure through Jun 2026 stood at 1.1 (up 8.01% YoY), while the FY2025 annual figure was 1.2, down 31.64% from the prior year.
• EV to EBITDA came in at 1.32 for Q2 2026 at Bausch Health Companies, up from 1.77 in the prior quarter.
• In the past five years, EV to EBITDA ranged from a high of 226.12 in Q3 2023 to a low of 11.16 in Q4 2022.
• Average EV to EBITDA over 5 years is 19.53, with a median of 7.9 recorded in 2023.
• Year-over-year, EV to EBITDA slumped 143.51% in 2022 and surged 1767.94% in 2023.
• Over 5 years, EV to EBITDA stood at 11.16 in 2022, then jumped by 171.96% to 8.03 in 2023, then plunged by 39.28% to 4.88 in 2024, then fell by 5.63% to 4.6 in 2025, then tumbled by 71.39% to 1.32 in 2026.
• Per Business Quant data, the three most recent EV to EBITDA figures were 1.32 in Q2 2026, 1.77 in Q1 2026, and 4.6 in Q4 2025.